Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY

v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2022   7,976,980    
Beginning balance at Dec. 31, 2022 $ 121,333 $ 1 $ 300,645 $ (179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   41,502    
Stock-based compensation 6,361   6,361  
Net loss (23,527)     (23,527)
Ending balance (in shares) at Mar. 31, 2023   8,018,482    
Ending balance at Mar. 31, 2023 $ 104,167 $ 1 307,006 (202,840)
Beginning balance (in shares) at Dec. 31, 2023 8,311,229 8,311,237    
Beginning balance at Dec. 31, 2023 $ 15,273 $ 1 318,600 (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   126,305    
Stock-based compensation (670)   (670)  
Net loss $ (24,050)     (24,050)
Ending balance (in shares) at Mar. 31, 2024 8,437,542 8,437,542    
Ending balance at Mar. 31, 2024 $ (9,447) $ 1 $ 317,930 $ (327,378)